BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/25/2021 6:05:27 AM | Browse: 474 | Download: 1589
 |
Received |
|
2020-10-29 07:47 |
|
Peer-Review Started |
|
2020-10-29 07:48 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-11-30 02:12 |
|
Revised |
|
2020-12-09 12:52 |
|
Second Decision |
|
2020-12-24 10:19 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-12-27 05:02 |
|
Articles in Press |
|
2020-12-27 05:02 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-01-15 01:58 |
|
Typeset the Manuscript |
|
2021-01-22 03:02 |
|
Publish the Manuscript Online |
|
2021-01-25 06:05 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Transplantation |
| Manuscript Type |
Clinical Trials Study |
| Article Title |
Effect of remote ischemic preconditioning among donors and recipients following pediatric liver transplantation: A randomized clinical trial
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Bo Qi, Xiao-Qiang Wang, Shu-Ting Pan, Pei-Ying Li, Ling-Ke Chen, Qiang Xia, Li-Qun Yang and Wei-Feng Yu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Renji Hospital Clinical Innovation Foundation |
PYIII-17-002 |
| Outstanding Academic Leaders’ Program of Health and Family Planning Commission of Shanghai |
2017BR042 |
| Investigative Doctor Program (2017) of Shanghai Jiao Tong University School of Medicine |
|
| Joint Project of Health and Family Planning Commission of Pudong District |
PW2015D-3 |
|
| Corresponding Author |
Wei-Feng Yu, PhD, Chief Doctor, Department of Anesthesiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, No. 160 Pujian Road, Shanghai 200127, China. ywf808@yeah.net |
| Key Words |
pediatric liver transplantation; remote ischemic preconditioning; postoperative complications; ischemia reperfusion injury; primary nonfunction; hepatology |
| Core Tip |
Ischemia reperfusion injury (IRI) has been a well-known underlying cause for inducing or aggravating primary graft nonfunction, vascular complications, and biliary complications during liver transplantation (LT). Some studies suggested that remote ischemic preconditioning (RIPC) may effectively lessen the harmful effects of IRI during organ transplantation surgery. However, studies on the effect of RIPC on pediatric LT were rare. The present single-center randomized clinical trial aimed to determine whether RIPC could be beneficial for reducing IRI among both donors and recipients undergoing pediatric LT. |
| Publish Date |
2021-01-25 06:05 |
| Citation |
Qi B, Wang XQ, Pan ST, Li PY, Chen LK, Xia Q, Yang LQ, Yu WF. Effect of remote ischemic preconditioning among donors and recipients following pediatric liver transplantation: A randomized clinical trial. World J Gastroenterol 2021; 27(4): 345-357 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i4/345.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i4.345 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
